Phase I Dose Escalation of Iodine-131–Metaiodobenzylguanidine With Myeloablative Chemotherapy and Autologous Stem-Cell Transplantation in Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Consortium Study - Concepedia

Concepedia

Publication | Open Access

Phase I Dose Escalation of Iodine-131–Metaiodobenzylguanidine With Myeloablative Chemotherapy and Autologous Stem-Cell Transplantation in Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Consortium Study

DOI Full Paper Access

192

Citations

27

References

2006

Year

Katherine K. Matthay, Jessica Tan, Judith G. Villablanca, Gregory A. Yanik, Janet Veatch, Benjamin L. Franc, Eilish Twomey, Biljana Horn, C. Patrick Reynolds, Susan Groshen,

Journal of Clinical Oncology

Abstract

131I-MIBG with myeloablative chemotherapy is feasible and effective for patients with neuroblastoma exhibiting de novo resistance to chemotherapy.

References

	Year	Citations

Page 1